Free Trial

Biomerica (BMRA) Competitors

$0.61
-0.01 (-1.61%)
(As of 05/28/2024 ET)

BMRA vs. SDC, ICCC, AWH, OCX, CDIO, MYMD, VRAX, NAVB, NVST, and XRAY

Should you be buying Biomerica stock or one of its competitors? The main competitors of Biomerica include SmileDirectClub (SDC), ImmuCell (ICCC), Aspira Women's Health (AWH), OncoCyte (OCX), Cardio Diagnostics (CDIO), MyMD Pharmaceuticals (MYMD), Virax Biolabs Group (VRAX), Navidea Biopharmaceuticals (NAVB), Envista (NVST), and DENTSPLY SIRONA (XRAY). These companies are all part of the "medical" sector.

Biomerica vs.

Biomerica (NASDAQ:BMRA) and SmileDirectClub (NASDAQ:SDC) are both small-cap medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their community ranking, analyst recommendations, dividends, institutional ownership, profitability, risk, media sentiment, valuation and earnings.

SmileDirectClub has a net margin of -19.94% compared to Biomerica's net margin of -117.46%. SmileDirectClub's return on equity of 0.00% beat Biomerica's return on equity.

Company Net Margins Return on Equity Return on Assets
Biomerica-117.46% -64.00% -50.95%
SmileDirectClub -19.94%N/A -14.55%

Biomerica has a beta of -0.92, indicating that its share price is 192% less volatile than the S&P 500. Comparatively, SmileDirectClub has a beta of 2.42, indicating that its share price is 142% more volatile than the S&P 500.

22.3% of Biomerica shares are owned by institutional investors. Comparatively, 4.3% of SmileDirectClub shares are owned by institutional investors. 13.5% of Biomerica shares are owned by company insiders. Comparatively, 64.7% of SmileDirectClub shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

Biomerica received 33 more outperform votes than SmileDirectClub when rated by MarketBeat users. Likewise, 67.82% of users gave Biomerica an outperform vote while only 61.54% of users gave SmileDirectClub an outperform vote.

CompanyUnderperformOutperform
BiomericaOutperform Votes
137
67.82%
Underperform Votes
65
32.18%
SmileDirectClubOutperform Votes
104
61.54%
Underperform Votes
65
38.46%

Biomerica has higher earnings, but lower revenue than SmileDirectClub. Biomerica is trading at a lower price-to-earnings ratio than SmileDirectClub, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Biomerica$5.41M1.90-$7.14M-$0.37-1.65
SmileDirectClub$414.88M0.00-$86.40M-$0.65N/A

In the previous week, Biomerica had 2 more articles in the media than SmileDirectClub. MarketBeat recorded 3 mentions for Biomerica and 1 mentions for SmileDirectClub. Biomerica's average media sentiment score of 0.92 beat SmileDirectClub's score of 0.00 indicating that Biomerica is being referred to more favorably in the media.

Company Overall Sentiment
Biomerica Positive
SmileDirectClub Neutral

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Biomerica
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
N/A
SmileDirectClub
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
N/A

Summary

Biomerica and SmileDirectClub tied by winning 7 of the 14 factors compared between the two stocks.

Get Biomerica News Delivered to You Automatically

Sign up to receive the latest news and ratings for BMRA and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding BMRA and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

BMRA vs. The Competition

MetricBiomericaDiagnostic substances IndustryMedical SectorNASDAQ Exchange
Market Cap$10.30M$3.01B$5.00B$8.09B
Dividend YieldN/A0.69%2.74%3.96%
P/E Ratio-1.65157.16176.4818.43
Price / Sales1.9081.162,386.6172.31
Price / CashN/A18.6833.0728.77
Price / Book0.873.704.944.39
Net Income-$7.14M$36.23M$104.35M$213.55M
7 Day Performance-6.99%-1.75%-0.63%-0.80%
1 Month Performance-8.00%2.60%3.85%3.42%
1 Year Performance-60.26%-27.37%5.47%7.53%

Biomerica Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
SDC
SmileDirectClub
0 of 5 stars
N/AN/AN/A$30.20M$414.88M-0.122,700News Coverage
Gap Down
High Trading Volume
ICCC
ImmuCell
0 of 5 stars
$4.54
-0.4%
N/A-17.9%$35.46M$17.47M-8.9074Short Interest ↓
Positive News
AWH
Aspira Women's Health
1.1722 of 5 stars
$2.29
-1.7%
$4.45
+94.3%
-36.6%$28.51M$9.15M-1.5864Analyst Forecast
High Trading Volume
OCX
OncoCyte
2.3267 of 5 stars
$2.83
-0.2%
$4.06
+43.6%
-37.4%$23.40M$1.50M0.0043Positive News
CDIO
Cardio Diagnostics
1.9784 of 5 stars
$0.69
-2.0%
$1.35
+96.9%
-52.4%$15.56M$20,000.000.007Short Interest ↑
MYMD
MyMD Pharmaceuticals
0 of 5 stars
$2.00
flat
N/A-96.9%$4.62MN/A0.006Short Interest ↓
Gap Down
VRAX
Virax Biolabs Group
0 of 5 stars
$0.90
+8.0%
N/A-78.3%$1.40M$10,000.000.0011Positive News
Gap Down
NAVB
Navidea Biopharmaceuticals
0 of 5 stars
$0.00
-99.7%
N/A-99.9%$10,000.00$70,000.000.0011Gap Down
NVST
Envista
4.2896 of 5 stars
$18.25
+1.6%
$25.86
+41.7%
-45.8%$3.14B$2.57B-25.3512,800Short Interest ↓
XRAY
DENTSPLY SIRONA
4.9089 of 5 stars
$27.46
-0.2%
$35.22
+28.3%
-25.2%$5.70B$3.94B-62.4115,000Dividend Announcement
Analyst Revision

Related Companies and Tools

This page (NASDAQ:BMRA) was last updated on 5/29/2024 by MarketBeat.com Staff

From Our Partners